Cargando…

Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015

Pseudomonas aeruginosa is intrinsically resistant to many antimicrobial drugs, making carbapenems crucial in clinical management. During July–October 2015 in the United States, we piloted laboratory-based surveillance for carbapenem-resistant P. aeruginosa (CRPA) at sentinel facilities in Georgia, N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walters, Maroya Spalding, Grass, Julian E., Bulens, Sandra N., Hancock, Emily B., Phipps, Erin C., Muleta, Daniel, Mounsey, Jackie, Kainer, Marion A., Concannon, Cathleen, Dumyati, Ghinwa, Bower, Chris, Jacob, Jesse, Cassidy, P. Maureen, Beldavs, Zintars, Culbreath, Karissa, Phillips, Walter E., Hardy, Dwight J., Vargas, Roberto L., Oethinger, Margret, Ansari, Uzma, Stanton, Richard, Albrecht, Valerie, Halpin, Alison Laufer, Karlsson, Maria, Rasheed, J. Kamile, Kallen, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2019
Materias:	Synopsis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590762/ https://www.ncbi.nlm.nih.gov/pubmed/31211681 http://dx.doi.org/10.3201/eid2507.181200

Ejemplares similares

Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012–2015
por: Bulens, Sandra N., et al.
Publicado: (2018)

1800 Phenotypic Definitions for Identifying Carbapenemase-Producing Carbapenem-resistant Enterobacteriaceae
por: Chea, Nora, et al.
Publicado: (2014)

Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015
por: Ansari, Uzma, et al.
Publicado: (2017)

Wide Range of Carbapenem-resistant Enterobacteriaceae Incidence and Trends in Emerging Infections Program Surveillance, 2012–2015
por: Duffy, Nadezhda, et al.
Publicado: (2017)

356 Epidemiology of Community-Associated Carbapenem-Resistant Enterobacteriaceae Identified through the Emerging Infections Program
por: Bulens, Sandra, et al.
Publicado: (2014)

Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae
por: Chea, Nora, et al.
Publicado: (2015)

Socioeconomic Status Factors Associated with Increased Incidence of Community-Associated Clostridium difficile Infection
por: Skrobarcek, Kimberly, et al.
Publicado: (2017)

1162. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified Through the Emerging Infections Program (EIP), United States, 2016–2017
por: Grass, Julian, et al.
Publicado: (2018)

1761. Effect of Carbapenem-Resistant Enterobacteriaceae (CRE) Surveillance Case Definition Change on CRE Epidemiology—Selected US Sites, 2015–2016
por: Duffy, Nadezhda, et al.
Publicado: (2018)

507. Epidemiology of Community-Associated Carbapenemase + Producing Carbapenem-Resistant Enterobacteriacae Identified from the Emerging Infections Program, 2012–2017
por: See, Isaac, et al.
Publicado: (2019)

482. Association between Socioeconomic Status Factors and Incidence of Community-Associated Clostridium difficile Infection Utilizing Factor Analysis—United States, 2014–2015
por: Skrobarcek, Kimberly, et al.
Publicado: (2018)

137 Developing an Approach to Evaluating the Quality of Antibiotic Prescribing in Hospitalized Patients with Community-Acquired Pneumonia (CAP) and Non-catheter Associated Urinary Tract Infection (UTI)
por: Fagan, Ryan, et al.
Publicado: (2014)

Reduction in the Prevalence of Healthcare-Associated Infections in U.S. Acute Care Hospitals, 2015 vs 2011
por: Magill, Shelley S, et al.
Publicado: (2017)

486. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified through the Emerging Infections Program (EIP), United States, 2016–2018
por: Grass, Julian E, et al.
Publicado: (2019)

“It’s like fighting a war with rocks”: Nursing home healthcare workers’ experiences during the COVID-19 pandemic
por: Seshadri, Sandhya, et al.
Publicado: (2020)

357 Epidemiology of Carbapenem-Resistant Gram-Negative Bacilli in Georgia, Minnesota, and Oregon – 2012
por: Guh, Alice, et al.
Publicado: (2014)

1640 Antibiotic Use Patterns in a Population with Long Term Care-Onset C. difficile Infection Developing after Recent Hospitalization
por: Felsen, Christina, et al.
Publicado: (2014)

1928. Trends In Incidence of Carbapenem-Resistant Enterobacterales (CRE) In Seven US sites, 2016─2020
por: Duffy, Nadezhda, et al.
Publicado: (2023)

1641 Evaluation of Co-Infections among Patients with Community-Associated Clostridium difficile Infection
por: Cohen, Jessica, et al.
Publicado: (2014)

1726 What Defines Carbapenem-Resistant Enterobacteriaceae (CRE) in a Low Prevalence State? Oregon, 2010 — 2013
por: Maureen Cassidy, P., et al.
Publicado: (2014)

606. Identification and Characterization of HMB-2, a Novel Metallo-β-Lactamase in a Pseudomonas aeruginosa Isolate
por: Zhu, Wenming, et al.
Publicado: (2019)

Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection
por: Dantes, Raymund, et al.
Publicado: (2015)

Evaluation of viral co-infections among patients with community-associated Clostridioides difficile infection
por: Korhonen, Lauren, et al.
Publicado: (2020)

Risk Factors for Community-Associated Clostridium difficile Infection in Children
por: Weng, Mark, et al.
Publicado: (2017)

Vital Signs: Carbapenem-Resistant Enterobacteriaceae
por: Jacob, Jesse T., et al.
Publicado: (2013)

1933. Assessment of Effectiveness of mRNA COVID-19 Vaccines Among Health Care Personnel: Monroe County, NY December 2020-March 2022
por: Russ, Savanah, et al.
Publicado: (2022)

Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations
por: Lessa, Fernanda C., et al.
Publicado: (2014)

86. Antibiotic-resistant gram-negative bacterial infections among persons with or without a prior positive test for SARS-CoV-2 in 10 U.S. sites, 2020
por: Bulens, Sandra N, et al.
Publicado: (2022)

524 National estimates of incidence, recurrence, hospitalization, and death of nursing home-onset Clostridium difficile infections — United States, 2012
por: Hunter, Jennifer C., et al.
Publicado: (2014)

Outbreak of Nontuberculous Mycobacteria Joint Prosthesis Infections, Oregon, USA, 2010–2016
por: Buser, Genevieve L., et al.
Publicado: (2019)

Genomic Analysis of a Pan-Resistant Isolate of Klebsiella pneumoniae, United States 2016
por: de Man, Tom J. B., et al.
Publicado: (2018)

1428. Clinical Characteristics and Management of Nontuberculous Mycobacterial Infections in the Finger Lakes Region of New York
por: Croix, Michael, et al.
Publicado: (2022)

2458. Carbapenem-resistant Acinetobacter baumannii complex infections and SARS-CoV-2 positivity in 9 U.S. sites, 2020-2022
por: Bulens, Sandra N, et al.
Publicado: (2023)

Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes
por: Hunter, Jennifer C., et al.
Publicado: (2016)

Balancing Enthusiasm for Innovative Technologies with Optimizing Value: An Approach to Adopt New Laboratory Tests for Infectious Diseases Using Bloodstream Infections as Exemplar
por: Culbreath, Karissa, et al.
Publicado: (2015)

Epidemiology of carbapenem-resistant and extended-spectrum beta-lactamase-producing Enterobacterales in US children, 2016–2020
por: Grome, Heather, et al.
Publicado: (2023)

Hospital-Nursing Home Transfer Patterns and Influence on Nursing Home Clostridium difficile Infection Rates
por: Campbell, Lauren, et al.
Publicado: (2017)

1642 Identifying Targets for Prevention Through Clostridium difficile Population Surveillance
por: Dumyati, Ghinwa, et al.
Publicado: (2014)

Systematic review of antibiotic stewardship interventions for urinary tract infection management in the ambulatory setting
por: Munsiff, Sonal, et al.
Publicado: (2022)

217 The Oregon Antimicrobial Stewardship Collaborative (OASIS). Statewide Effectiveness on Re-Survey
por: Mohammadi, Jwan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_devpis16teobfbumdfe455f5d1